Skin Cancer: Etherna and Almirall Collaborate to Develop New mRNA Therapies
Almirall and Etherna announce a multi-target alliance to develop new mRNA therapies for severe skin diseases, such as non-melanoma skin cancer. A multi-target alliance to discover and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer, is what Almirall, a g...





